Non-oncology Biopharmaceuticals Market Report

Global and Region Non-oncology Biopharmaceuticals Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：175
  • REPORT CODE：GMM980502
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Non-oncology Biopharmaceuticals market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Non-oncology Biopharmaceuticalsmarket, defines the market attractiveness level of Non-oncology Biopharmaceuticals market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Non-oncology Biopharmaceuticals industry, describes the types of Non-oncology Biopharmaceuticals market, the applications of major players and the market size, and deeply analyzes the current situation of the global Non-oncology Biopharmaceuticals market and the development prospects and opportunities of Non-oncology Biopharmaceuticals industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Non-oncology Biopharmaceuticals market in Chapter 13.

    By Player:

    • Merck

    • Elusys Therapeutics

    • Bristol-Myers Squibb

    • Sanofi

    • LEO Pharma

    • AbbVie

    • UCB Pharma

    • Eli Lilly

    • Swedish Orphan Biovitrum

    • Biogen

    • Novartis

    • Mylan

    • Novo Nordisk

    • Pfizer

    • Amgen

    • Teva

    • Takeda

    • Boehringer Ingelheim

    • AstraZeneca

    • Alexion Pharmaceuticals

    • Johnson & Johnson

    • Roche

    • GlaxoSmithKline

    By Type:

    • Biologics

    • Biosimilars

    By End-User:

    • Immunology

    • Endocrinology

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Non-oncology Biopharmaceuticals Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Non-oncology Biopharmaceuticals Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Non-oncology Biopharmaceuticals Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Non-oncology Biopharmaceuticals Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Non-oncology Biopharmaceuticals Market Analysis and Outlook to 2022

    • 7.1 Global Non-oncology Biopharmaceuticals Consumption (2017-2022)

    • 7.2 United States Non-oncology Biopharmaceuticals Consumption (2017-2022)

    • 7.3 Europe Non-oncology Biopharmaceuticals Consumption (2017-2022)

    • 7.4 China Non-oncology Biopharmaceuticals Consumption (2017-2022)

    • 7.5 Japan Non-oncology Biopharmaceuticals Consumption (2017-2022)

    • 7.6 India Non-oncology Biopharmaceuticals Consumption (2017-2022)

    • 7.7 South Korea Non-oncology Biopharmaceuticals Consumption (2017-2022)

    8 Region and Country-wise Non-oncology Biopharmaceuticals Market Analysis and Outlook to 2028

    • 8.1 Global Non-oncology Biopharmaceuticals Consumption Forecast (2022-2028)

    • 8.2 United States Non-oncology Biopharmaceuticals Consumption Forecast (2022-2028)

    • 8.3 Europe Non-oncology Biopharmaceuticals Consumption Forecast (2022-2028)

    • 8.4 China Non-oncology Biopharmaceuticals Consumption Forecast (2022-2028)

    • 8.5 Japan Non-oncology Biopharmaceuticals Consumption Forecast (2022-2028)

    • 8.6 India Non-oncology Biopharmaceuticals Consumption Forecast (2022-2028)

    • 8.7 South Korea Non-oncology Biopharmaceuticals Consumption Forecast (2022-2028)

    9 Global Non-oncology Biopharmaceuticals Market Outlook by Types and Applications to 2022

    • 9.1 Global Non-oncology Biopharmaceuticals Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Biologics Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Biosimilars Consumption and Growth Rate (2017-2022)

    • 9.2 Global Non-oncology Biopharmaceuticals Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Immunology Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Endocrinology Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Non-oncology Biopharmaceuticals Market Outlook by Types and Applications to 2028

    • 10.1 Global Non-oncology Biopharmaceuticals Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Biologics Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Non-oncology Biopharmaceuticals Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Immunology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Endocrinology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Non-oncology Biopharmaceuticals Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Non-oncology Biopharmaceuticals Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Non-oncology Biopharmaceuticals Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Non-oncology Biopharmaceuticals Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Non-oncology Biopharmaceuticals Market Competitive Analysis

    • 14.1 Merck

      • 14.1.1 Merck Company Details

      • 14.1.2 Merck Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Merck Non-oncology Biopharmaceuticals Product and Service

    • 14.2 Elusys Therapeutics

      • 14.2.1 Elusys Therapeutics Company Details

      • 14.2.2 Elusys Therapeutics Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Elusys Therapeutics Non-oncology Biopharmaceuticals Product and Service

    • 14.3 Bristol-Myers Squibb

      • 14.3.1 Bristol-Myers Squibb Company Details

      • 14.3.2 Bristol-Myers Squibb Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Bristol-Myers Squibb Non-oncology Biopharmaceuticals Product and Service

    • 14.4 Sanofi

      • 14.4.1 Sanofi Company Details

      • 14.4.2 Sanofi Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Sanofi Non-oncology Biopharmaceuticals Product and Service

    • 14.5 LEO Pharma

      • 14.5.1 LEO Pharma Company Details

      • 14.5.2 LEO Pharma Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 LEO Pharma Non-oncology Biopharmaceuticals Product and Service

    • 14.6 AbbVie

      • 14.6.1 AbbVie Company Details

      • 14.6.2 AbbVie Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 AbbVie Non-oncology Biopharmaceuticals Product and Service

    • 14.7 UCB Pharma

      • 14.7.1 UCB Pharma Company Details

      • 14.7.2 UCB Pharma Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 UCB Pharma Non-oncology Biopharmaceuticals Product and Service

    • 14.8 Eli Lilly

      • 14.8.1 Eli Lilly Company Details

      • 14.8.2 Eli Lilly Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Eli Lilly Non-oncology Biopharmaceuticals Product and Service

    • 14.9 Swedish Orphan Biovitrum

      • 14.9.1 Swedish Orphan Biovitrum Company Details

      • 14.9.2 Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Product and Service

    • 14.10 Biogen

      • 14.10.1 Biogen Company Details

      • 14.10.2 Biogen Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Biogen Non-oncology Biopharmaceuticals Product and Service

    • 14.11 Novartis

      • 14.11.1 Novartis Company Details

      • 14.11.2 Novartis Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Novartis Non-oncology Biopharmaceuticals Product and Service

    • 14.12 Mylan

      • 14.12.1 Mylan Company Details

      • 14.12.2 Mylan Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Mylan Non-oncology Biopharmaceuticals Product and Service

    • 14.13 Novo Nordisk

      • 14.13.1 Novo Nordisk Company Details

      • 14.13.2 Novo Nordisk Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Novo Nordisk Non-oncology Biopharmaceuticals Product and Service

    • 14.14 Pfizer

      • 14.14.1 Pfizer Company Details

      • 14.14.2 Pfizer Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Pfizer Non-oncology Biopharmaceuticals Product and Service

    • 14.15 Amgen

      • 14.15.1 Amgen Company Details

      • 14.15.2 Amgen Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Amgen Non-oncology Biopharmaceuticals Product and Service

    • 14.16 Teva

      • 14.16.1 Teva Company Details

      • 14.16.2 Teva Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Teva Non-oncology Biopharmaceuticals Product and Service

    • 14.17 Takeda

      • 14.17.1 Takeda Company Details

      • 14.17.2 Takeda Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Takeda Non-oncology Biopharmaceuticals Product and Service

    • 14.18 Boehringer Ingelheim

      • 14.18.1 Boehringer Ingelheim Company Details

      • 14.18.2 Boehringer Ingelheim Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Boehringer Ingelheim Non-oncology Biopharmaceuticals Product and Service

    • 14.19 AstraZeneca

      • 14.19.1 AstraZeneca Company Details

      • 14.19.2 AstraZeneca Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.19.3 AstraZeneca Non-oncology Biopharmaceuticals Product and Service

    • 14.20 Alexion Pharmaceuticals

      • 14.20.1 Alexion Pharmaceuticals Company Details

      • 14.20.2 Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.20.3 Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Product and Service

    • 14.21 Johnson & Johnson

      • 14.21.1 Johnson & Johnson Company Details

      • 14.21.2 Johnson & Johnson Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.21.3 Johnson & Johnson Non-oncology Biopharmaceuticals Product and Service

    • 14.22 Roche

      • 14.22.1 Roche Company Details

      • 14.22.2 Roche Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.22.3 Roche Non-oncology Biopharmaceuticals Product and Service

    • 14.23 GlaxoSmithKline

      • 14.23.1 GlaxoSmithKline Company Details

      • 14.23.2 GlaxoSmithKline Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

      • 14.23.3 GlaxoSmithKline Non-oncology Biopharmaceuticals Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Non-oncology Biopharmaceuticals

    • Figure Non-oncology Biopharmaceuticals Picture

    • Table Global Non-oncology Biopharmaceuticals Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Non-oncology Biopharmaceuticals Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Non-oncology Biopharmaceuticals Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Non-oncology Biopharmaceuticals Consumption by Country (2017-2022)

    • Figure United States Non-oncology Biopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Table Europe Non-oncology Biopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure China Non-oncology Biopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Japan Non-oncology Biopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure India Non-oncology Biopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure South Korea Non-oncology Biopharmaceuticals Consumption and Growth Rate (2017-2022)

    • Figure Global Non-oncology Biopharmaceuticals Consumption Forecast by Country (2022-2028)

    • Figure United States Non-oncology Biopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Non-oncology Biopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Non-oncology Biopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Non-oncology Biopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Non-oncology Biopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Non-oncology Biopharmaceuticals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biologics Consumption and Growth Rate (2017-2022)

    • Figure Global Biosimilars Consumption and Growth Rate (2017-2022)

    • Figure Global Immunology Consumption and Growth Rate (2017-2022)

    • Figure Global Endocrinology Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Biologics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biosimilars Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Endocrinology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Non-oncology Biopharmaceuticals Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Non-oncology Biopharmaceuticals Export by Region (Top 5 Countries) (2017-2028)

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Non-oncology Biopharmaceuticals Product and Service

    • Table Elusys Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Elusys Therapeutics Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Elusys Therapeutics Non-oncology Biopharmaceuticals Product and Service

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Non-oncology Biopharmaceuticals Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Non-oncology Biopharmaceuticals Product and Service

    • Table LEO Pharma (Foundation Year, Company Profile and etc.)

    • Table LEO Pharma Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table LEO Pharma Non-oncology Biopharmaceuticals Product and Service

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Non-oncology Biopharmaceuticals Product and Service

    • Table UCB Pharma (Foundation Year, Company Profile and etc.)

    • Table UCB Pharma Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table UCB Pharma Non-oncology Biopharmaceuticals Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Non-oncology Biopharmaceuticals Product and Service

    • Table Swedish Orphan Biovitrum (Foundation Year, Company Profile and etc.)

    • Table Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Swedish Orphan Biovitrum Non-oncology Biopharmaceuticals Product and Service

    • Table Biogen (Foundation Year, Company Profile and etc.)

    • Table Biogen Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen Non-oncology Biopharmaceuticals Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Non-oncology Biopharmaceuticals Product and Service

    • Table Mylan (Foundation Year, Company Profile and etc.)

    • Table Mylan Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan Non-oncology Biopharmaceuticals Product and Service

    • Table Novo Nordisk (Foundation Year, Company Profile and etc.)

    • Table Novo Nordisk Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk Non-oncology Biopharmaceuticals Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Non-oncology Biopharmaceuticals Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Non-oncology Biopharmaceuticals Product and Service

    • Table Teva (Foundation Year, Company Profile and etc.)

    • Table Teva Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Non-oncology Biopharmaceuticals Product and Service

    • Table Takeda (Foundation Year, Company Profile and etc.)

    • Table Takeda Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Non-oncology Biopharmaceuticals Product and Service

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Non-oncology Biopharmaceuticals Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Non-oncology Biopharmaceuticals Product and Service

    • Table Alexion Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alexion Pharmaceuticals Non-oncology Biopharmaceuticals Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Non-oncology Biopharmaceuticals Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Non-oncology Biopharmaceuticals Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Non-oncology Biopharmaceuticals Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Non-oncology Biopharmaceuticals Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US